Sales and Marketing

Showing 15 posts of 11524 posts found.

Sandoz to acquire generic injectables business

May 28, 2009 Sales and Marketing generics

Sandoz, the generics arm of Novartis, is to acquire the generic injectables business of Austrian company EBEWE Pharma.The deal, which …

Sanofi adds to cancer pipeline with Exelixis deal

May 28, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed a deal with oncology-focused biotech Exelixis to co-develop two new cancer treatments.The alliance will see Sanofi gain …

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009 Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …

Demonstrating value to boost product uptake

May 27, 2009 Sales and Marketing marketing, product, value

I am sure that every marketer reading Pharmafocus is convinced of the value of their brand. Why then do so …

GP targets drive up COPD prescribing

May 27, 2009 Sales and Marketing COPD, NHS, qof

Respiratory drugs saw the biggest growth in GP prescribing in England in 2008, thanks to new COPD targets.The rapid growth …

Almirall opens UK headquarters

May 27, 2009 Sales and Marketing Almirall

Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …

Sanofi launches web TV channel

May 21, 2009 Sales and Marketing Sanofi-Aventis, digi

Sanofi-Aventis has set up an online television channel to promote its business, commitment to social responsibility and employee activities. To …

Phase III drug superior to Spiriva, says Novartis

May 21, 2009 Research and Development, Sales and Marketing COPD, Novarits

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …

Pfizer signs Indian generic deals

May 21, 2009 Sales and Marketing Pfizer, generics

Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …

ABPI looks to breathe new life into industry relations

May 20, 2009 Medical Communications, Sales and Marketing ABPI, doctors, industry relations, medical education, vita

The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …

Takeda to market new bone cancer drug

May 20, 2009 Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …

Cannabis-derived MS drug filed for European approval

May 20, 2009 Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009 Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …

EU gives the nod to Teva/Lonza biosimilar venture

May 18, 2009 Manufacturing and Production, Sales and Marketing Lonza, Teva

The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …

The medical-marketing interface and how to bridge the gap

May 18, 2009 Research and Development, Sales and Marketing marketing, medical

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
The Gateway to Local Adoption Series

Latest content